European medicines group appoints Bayer’s Alex Moscho as new chair
July 7, 2015Manufacturing and Production, Research and Development, Sales and Marketing Alexander Moscho, EMG, European Medicines Group
Leading UK industry group the European Medicines Group (EMG) has elected Dr Alexander Moscho, the managing director of Bayer UK …
Pharma ‘paid US doctors $1.5 billion’ in 2014
July 7, 2015Medical Communications, Sales and Marketing Sunshine Act, US, pharma
Some of the largest European drugmakers paid US doctors and teaching hospitals $1.5 billion in 2014 to participate in promotional …
Teva ‘to increase Mylan bid to $43bn’
July 7, 2015Sales and Marketing M&A, MA, Mylan, Teva, generics
Israeli drugmaker Teva is considering whether to up its bid for US rival firm Mylan, with reports that it could …
Prescribing in England up 55% to £9bn over a decade
July 7, 2015Manufacturing and Production, Sales and Marketing NHS, NHSIC, drugs, health and social care information centre, net ingredient cost, prescribing
The number of drugs issued in England continues to soar, according to the latest NHS figures which show prescribing in …
Biogen to build billion-dollar plant in Switzerland
July 7, 2015Manufacturing and Production Alzherimer's disease, Biogen, Biogen IDEC, MS, Switzerland, manufacturing, multiple sclerosis
Biogen plans to open a $1 billion manufacturing facility in Switzerland, to help Europe deal with the future demand for …
Novo Nordisk pulls Tresiba in Germany after pricing row
July 6, 2015Manufacturing and Production, Sales and Marketing Drug pricing, Germany, Novo Nordisk, Reimbursement, Tresiba, market access
Novo Nordisk has discontinued its distribution of once-daily basal insulin Tresiba after pricing talks with the German body that represents …
Working Life: Bayer UK & Ireland’s chief executive Alexander Moscho
July 6, 2015Manufacturing and Production, Research and Development, Sales and Marketing Alexander Moscho, Bayer
How did you find your way into your current role?I think it started when I was young and I was …
Adam Zaeske appointed as managing director of Takeda UK and Ireland
July 6, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adam Zaeske, Takeda
Japanese pharma firm Takeda has appointed Adam Zaeske as managing director of Takeda UK and Ireland.Zaeske has been with Takeda …
NHS England approves AbbVie’s Duodopa for Parkinson’s disease
July 6, 2015Sales and Marketing AbbVie, Duodopa, James Palmer, NHS England, PPRS, Parkinson's, Parkinson's disease, commissioning
AbbVie has been handed a boost by NHS England, who has approved the prescribing of its Parkinson’s disease treatment Duodopa …
Vertex’s cystic fibrosis drug gets FDA approval
July 3, 2015Research and Development, Sales and Marketing FDA, Orkambi, Vertex, cystic fibrosis, gene therapy
Vertex Pharmaceuticals cystic-fibrosis drug Orkambi, which could treat as many as 8,500 patients in the US, has been approved by …
Sanofi’s Toujeo approved in Japan
July 3, 2015Manufacturing and Production, Sales and Marketing Japan, Lantus Lantus XR, Sanofi, diabetes, toujeo, type diabetes
The Ministry of Health, Labor and Welfare in Japan has given Sanofi a marketing authorisation for the diabetes drug the …
Astellas in ‘unacceptable’ Xtandi ABPI code breach
July 3, 2015Medical Communications, Sales and Marketing ABPI Code, Astella, PMCPA, Xtandi
The industry code of conduct regulator has singled out Astellas for ‘particular censure’ for arranging a meeting for UK healthcare …
Prices to be printed on all prescribed NHS drugs over £20
July 2, 2015Manufacturing and Production, Medical Communications, Sales and Marketing Jeremy Hunt, NHS, UK, drugs, health secretary, medicines
NHS drugs costing more than £20 will, from next year, have the price and the words “funded by the UK …
Boehringer Ingelheim launches Spiolto for COPD
July 2, 2015Sales and Marketing Boehringer Ingelheim, COPD, Europe, Spiolto, Spiriva, Striverdi
Boehringer Ingelheim is beginning a new push in lung disease across Europe after being approved by regulators in nine countries …
Pharma outsourcing: CROs, CMOs and external collaboration
July 2, 2015Manufacturing and Production, Research and Development CMOs, R&D, clinical trials, collaboration, cros, outsourcing
Thirty years ago pharma companies seemed to use external contractors as a sort of fire brigade, to be called in …
Mission Therapeutics appoints Dr Colin Goddard to its board of directors
July 2, 2015Research and Development Colin Goddard, Mission Therapeutics, appointments
MISSION Therapeutics, a drug discovery and development company today has appointed Dr Colin Goddard, former chief executive of OSI Pharmaceuticals, …
Opdivo launched in the UK for skin cancer
July 2, 2015Sales and Marketing BMS, Bristol-Myers Squibb, EMA, Early Access to Medicines Scheme, MHRA, eams, melanoma, opdivo, skin cancer
Bristol-Myers Squibb has launched its cancer immunotherapy treatment Opdivo in the UK for patients with advanced skin cancer. Opdivo (nivolumab) …
DJM Unlimited makes new director appointment
July 1, 2015Medical Communications DJM Unlimited, Michael Le Brocq
UK and US based company DJM Unlimited has appointed Michael Le Brocq as board director. Le Brocq has 20 years’ …
Pfizer partners with NIHR to boosts UK R&D
July 1, 2015Research and Development Manchester, NIHR, Pfizer, R&D, Sally Davies
Pfizer has signed an agreement with the National Institute for Health Research Clinical Research Network to conduct more clinical research …
Novartis launches ViaOpta Apple Watch app
July 1, 2015Medical Communications Novartis, apple watch, apps, visual impairment, wearables
Novartis has launched new features of its ViaOpta app for use with the Apple Watch and other wearable devices. The …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
